Reddit Posts
Special Situation $GOSS w/over 23 million shares short
Special Situation $GOSS w/over 23 million shares short
The Biotech Train is leaving the Station. All Aboard!: $LUMO, $BIVI, $GOSS
Top penny stocks to keep an eye on for less than $1
Gossamer Bio Inc. (GOSS) Has Recovered 24.79% From Its Low
GOSS - Several indicators this should pop tomorrow.
Short Squeeze Pennies To Watch - $RAD $SANA $GOEV $GOSS
GOSS is the real deal and has been shorted to a bargain price
$GOSS Gossamer Bio Inc According to Yahoo Finance: 130.60% of Shares Held by Institutions
GOSS fell from $9 to 1.59 today, anyone with more info about?
$GOSS is a new shortsqueeze opportunity?
$GOSS is a new shortsqueeze opportunity?
Mentions
spam posts every day abt a sh\*tty website, lol. There is no big flow in GOSS, I checked unusualwhales.
$GOSS $4 calls high OI 1/16/2026, biotech, has a huge gap fill to $8
I was in GOSS for a while, but at this price the risk feels asymmetric to the downside. The lack of obvious adverse events sounds encouraging, but it also raises the real possibility that efficacy is simply not strong enough to meet the primary endpoint. We have seen this recently with XOMA’s partner Rezolute missing in Phase 3, and XOMA is also tied to Gossamer. Late stage trials still fail at meaningful rates, and PAH in particular has noisy endpoints and significant patient heterogeneity. What worries me more is the setup from here. If the data are anything short of clearly positive, the stock likely reprices hard, and even decent but ambiguous results may not be enough to support the valuation. Burn continues, and it seems increasingly likely they need to raise more cash before or after data, which adds dilution risk at a time when sentiment would already be fragile. There will be winners and losers here, but today this looks more like a binary gamble than a mispriced opportunity. I would rather step aside than ride that coin flip, but I will be watching closely.
GOSS (Bio), SOUN (AI), TSLA (Tech/Auto), NVDA (AI), META, CRWV (AI). These are all priced at a discount right now. Not saying it won't go lower, but eventually these stocks are bound to shoot back up!
Anyone in long on GOSS? It's definitely not a momentum play, but analysts have its price target \~$8.50-$9 on average. It's currently at $2.38 with low volatility as of now. I'm thinking about opening a long position myself.
Agree. I’m holding $GOSS rn, big news January - February.
I think GOSS is gonna pump tomorrow.
GOSS is dipping right now
GOSS is a little different from ATYR. ATYR’s big Phase 3 just missed its primary endpoint, while GOSS is still in the middle of its pivotal trial. PROSERA builds on the earlier TORREY Phase 2 — same drug, but much larger (390 vs 86 patients) and with a sicker cohort (74% FC III vs \~42% in TORREY, worse baseline walk distance and NT-proBNP). The design was refined to give a clearer read on efficacy, and topline results are expected Feb 2026.
Anyone know why GOSS is down?? analyst price is 8, strong buy, no update on phase 3 so far that i know of. No big news
So small caps pharma stocks are tricky, in that we dont know when the run up will start, could be before a decision, (Run up like GOSS 80c to 3.50), or it could be the PFUDFA date which is the 13Dec2025 and we see a 100% rise if there is not run up. Generally I try to buy before the run up so I do hold stocks a bit
Def looking at ACHV (PDUFA next year) SPRO (PDUFA next year with partner), GOSS (Data in Feb2026) and INO (Maybe approval mid 2026) along with QNCX (Data 1st Q 2026)
If anyone’s interested in something not mentioned yet, $GOSS has been on my watchlist for a while and it’s been picking up momentum. Not in it yet, haven’t really done DD but I’ll come back with some in a bit
No catalyst today or near future (Phase 3 readout in Feb 2026), so I can't explain it - but GOSS continues to march up I've been slowly DCA'ing to my position, but feel like I've missed out trying to wait for a pullback. It's a 80% + institutional owned stock so I like the risk/reward profile
$GOSS is headed in the right direction. StockInvest.us projects a possible 100%+ gain over the next three months, with a 90% confidence range predicting the stock to land between $4.28 and $5.3. It’s currently $2.51 btw
Much appreciated insight! All of my investments are in a Vanguard Roth IRA, so while I’m making slight changes short term, most of my moves are geared toward the long run. I’m 37. I’m trying to stick with companies with large upside, while also being a little risky, hoping that “small” investments payoff in the long run. Right now I’m up 250% on OKLO and have positions in GOSS and APMX. Everything I have read and researched about RZLV is similar to OKLO in the sense that it has some very promising long-term potential. I’m considering selling about 30 shares of OKLO that I bought at $20 to move into RZLV, but we’ll see. I like that RZLV is being well received by many and I don’t think AI is going anywhere.
Throw GOSS in there. It’s makin moves
I'll be watching GOSS next week for their commentary at investor conferences for any news on how their Phase 3 is going. Significant institutional ownership with a slow and steady price movement has caught my attention.
Anyone like the look of $GOSS
Anybody have any thoughts on GOSS?
Maybe you take you wanna take a look at GOSS?
I’ve been watching GOSS grow and grow for months. It’s been pretty consistent
GOSS Technical analysis supports what the fundamentals are suggesting: Gossamer is gearing up for a parabolic move. The stock has begun forming a bullish pattern with increasing volume, indicating institutional accumulation. If the anticipated news delivers as expected, a move past $10 per share is not just possible, it’s probable. This is a stock that’s been overlooked and underestimated. But that window is closing. The company is sending signals that something big is coming, and once the public announcement drops, the rush to get in could trigger a short squeeze and price surge rarely seen in this sector.
GOSS - Gossamer Bio at Sector Outperform With $11 Price Target. Price just over $2, take a look! Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Everyone should be looking at GOSS, almost doubling my money and going higher! $8 Price Target
OPTT and GOSS over the next week are worth keeping your eyes on
Anyone in GOSS? Been holding for a while and some nice movement today
$GOSS - currently $1.25, big institutional ownership, high call to put ratio, analyst forecasts average around $7 including Goldman Sachs
After doing my DD and consulting the shaman of the high plains. I have entered the realm of GOSS. Now for the magic 8-ball to guide me through this 🤪
GOSS is rising ranks pretty quick. Looks like ton of potential too!!
GOSS is rising ranks pretty quick. Looks like ton of potential too 😸
I am long on $GOSS in both calls and stock, and seeing it creep up has me VERY happy.
What's the plan for GOSS? Any update? I went balls deep into this company. When GOSS should have update on this treatment? Is there any deadlines to meet?
$GOSS several folks were talking about this one last month, any other bagholders out there?
RONN is moving up AEMD dropped for a good buying opportunity GOSS is still affordable but rising KBLB will soon have a buyer and contracts and should soar ARRNF is mining Strategic Defense metals IMHO-NFA
GOSS does whatever it feels like, but it did see a 7% jump after earnings. I am bullish tomorrow and I do feel like we'll have a green day for once, but don't expect much from it.
Ronn, inc. LLAP, GOSS, AEMD, KULR
GOSS I keep telling yall https://www.insidermonkey.com/blog/why-is-gossamer-bio-inc-goss-the-best-one-dollar-stock-to-buy-now-1325917/
I can guarantee that seralutinib nebulizer by GOSS will be a huge success. Promising 2nd phase results. Promising positive interim results. Does not compete with MRK’s new drug. Route of administration is unique to pulomnary hypertension. Will gain huge market share. Probably can be extended to interstitial ling disease. Both multi billion markets. GOSS can probably go up to 25 a share
Saw this a week late lol. Came here to look at $GOSS stuff
No feelings but great call on GOSS
I got in early for once yessssss!!! GOSS is definitely taking off
Has anyone else picked up on GOSS? I think these boys are set up to take off. I keep telling my boys lol smh, this comment will be my proof
GOSS The volatility is crazy and it’s a penny stock with some heart medicine in the works. Stocks been a stupidly good earner since I got in. I might get out sooner or later
$GOSS and $OPT are my hope for the end of the year 🙌💎🌊📈
GOSS, ABOS, CLNN,ATOS All mid to long plays with 4x to 10x potential, in my opinion do your own DD
if we look at 2022, GOSS was around $13.65, and now it's .90-ish... so it is down quite a bit... going back to 2109, GOSS was over $25... but in the 1-year view, it's roller-coastered down from 1.49 to where it is now... being down that much over all, it could bounce, or it could keep going down... what does your gut say? is your intuition usually right?... these are the questions that keep me up at night... imo... ymmv looks like insider(s) might be buying... apparently GOSS are 'the only ones doing what they're doing'... could be a hold... [https://finance.yahoo.com/quote/GOSS/community/](https://finance.yahoo.com/quote/GOSS/community/)
BTBT, LTBR, EOSE, GOSS I own puts on these 4 ranging from this Friday all the way to mid August. We shall see how they pan out.
GOSS... I keep saying it! Also long term check out CLNN
$GOSS may be interesting when its trading resumes (7:55am ET quote resumption time, 8:00am ET trade resumption time) gossamer bio and chiesi group announce transformative global collaboration to develop and commercialize seralutinib in pah, ph-ild & other indications https://ir.gossamerbio.com/news-releases/news-release-details/gossamer-bio-and-chiesi-group-announce-transformative-global/
GOSS, cheap shares (0.92-0.99) with high potential (analysts say 8-9$)
GOEV is no good ceo is dogshit and investors are pulling out, CUTR looks really good, gunna put 500$ in frist thing tmrw, And GOSS could be good if you wanna hold for 30 years
GOEV, CUTR, GOSS, all with an estimated profit of 300% minimum over 12months
LODE CREX GOSS CMPX NBY About 10% of my portfolio in that, so far so good Planning to keep for min 2y
My picks are biotech, OCUL, ARQT, GOSS, HROW, LRMR
heh yeah I was being sarcastic, but it comes from a good place, I am a GOSS bagholder
As soon as I can get even money on my 5000 GOSS shares I will put it all in NEGG promise
Five thousand (5000) shares of GOSS send their regards
Rotated out of that last tranche of BTM 🤡 a little bit prematurely— they ring the bell on Monday. Used the clown ‘oin gains to load some biotech follies heading into early August earnings reports. Biotech winter is over for my select synbio specific teams. Happy with how my ALLO, CDXS, and TWST are coming back from the beat down. Jury is still out on my GOSS, OMIC, and TBIO. But they are still holding the line. Bloomberg consulting with my Bitdeer crew’s other unicorn 🦄 Matrixport on the halving. So that’s a vote of confidence over the better known meme miners. Bloomberg conservatives predict 81% boost. 🤡🙌🔥
Sold the last tranche of that BTM, dumped my CORZ bankruptcy play, bought moar EVO, TWST, NVTA, and started new positions in beat down Follies: GOSS, VXRT. Covid testing in Japan is 42% positive and 25% of hospital supplies for all sterile injections were just knocked out by the Pfizer tornado. Shrugs shoulders. I’m up 10k this week and have no illusions it will hold up for next 48 hours.
How could they not know the reason when their investors disclose being long and short? [$GOSS: Institutional Owners: 284 total, 273 long only, 4 short only, 7 long/short](https://fintel.io/so/us/goss)
Thoughts on GOSS or GETY as short squeeze candidates?
[$CDTX Cidara Therapeutics with short volume overlaid in gold: FDA Advisory Committee Recommends Approval of Rezafungin for the Treatment of Candidemia and Invasive Candidiasis](https://www.reddit.com/r/Shortsqueeze/comments/10l068f/cdtx_cidara_therapeutics_with_short_volume/) [$GOSS Gossamer Bio Inc According to Yahoo Finance: 130.60% of Shares Held by Institutions](https://www.reddit.com/r/Shortsqueeze/comments/10l4xdl/goss_gossamer_bio_inc_according_to_yahoo_finance/)
I pulled out of GOSS yesterday, so it’s up 12% today.
Let’s pump $GOSS looking nice fell off from $9+ to $2 a few months ago seeing movement now
I like GOSS. An underrated stock that I believe should be worth around $9-$12. If I had $10k, I'd probably load up on that
I have one bio/meme/shitcoin play and it's $GOSS. Do you own research but it's a swing trade haven the last several trading days.
Weekend short covering? https://finance.yahoo.com/quote/GOSS/key-statistics?p=GOSS
Big spike for GOSS at EOD. Trying to figure out what's going on, LOL!
what is going on with GOSS? Anyone know?
$GOSS is a decent ticker too if you're looking for another play.